Report cover image

Short-Acting B2 Agonists Global Market Report 2025

Publisher The Business Research Company
Published Jul 01, 2025
Length 175 Pages
SKU # BRC20148842

Description

Short-Acting B2 Agonists Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on short-acting b2 agonists market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for short-acting b2 agonists ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The short-acting b2 agonists market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Albuterol; Levalbuterol; Metaproterenol; Other Types

2) By Indication: Asthama; Chronic Obstructive Pulmonary Disease (COPD); Exercise-Induced Bronchospasm

3) By Administration Route: Inhalation; Oral; Injection

4) By End User: Hospitals; Clinics; Home Healthcare Settings

Subsegments:

1) By Albuterol: Inhalers; Nebulizers; Tablets; Syrups

2) By Levalbuterol: Inhalers; Nebulizers; Oral Solutions

3) By Metaproterenol: Inhalers; Syrups

4) By Other Types: Terbutaline; Pirbuterol; Salbutamol

Companies Mentioned: AstraZeneca plc; Novartis AG; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Apotex Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Short-Acting B2 Agonists Market Characteristics
3. Short-Acting B2 Agonists Market Trends And Strategies
4. Short-Acting B2 Agonists Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Short-Acting B2 Agonists Growth Analysis And Strategic Analysis Framework
5.1. Global Short-Acting B2 Agonists PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Short-Acting B2 Agonists Market Growth Rate Analysis
5.4. Global Short-Acting B2 Agonists Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Short-Acting B2 Agonists Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Short-Acting B2 Agonists Total Addressable Market (TAM)
6. Short-Acting B2 Agonists Market Segmentation
6.1. Global Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Albuterol
Levalbuterol
Metaproterenol
Other Types
6.2. Global Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Asthama
Chronic Obstructive Pulmonary Disease (COPD)
Exercise-Induced Bronchospasm
6.3. Global Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalation
Oral
Injeaction
6.4. Global Short-Acting B2 Agonists Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Healthcare Settings
6.5. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Albuterol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalers
Nebulizers
Tablets
Syrups
6.6. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Levalbuterol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalers
Nebulizers
Oral Solutions
6.7. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Metaproterenol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalers
Syrups
6.8. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Terbutaline
Pirbuterol
Salbutamol
7. Short-Acting B2 Agonists Market Regional And Country Analysis
7.1. Global Short-Acting B2 Agonists Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Short-Acting B2 Agonists Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Short-Acting B2 Agonists Market
8.1. Asia-Pacific Short-Acting B2 Agonists Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Short-Acting B2 Agonists Market
9.1. China Short-Acting B2 Agonists Market Overview
9.2. China Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Short-Acting B2 Agonists Market
10.1. India Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Short-Acting B2 Agonists Market
11.1. Japan Short-Acting B2 Agonists Market Overview
11.2. Japan Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Short-Acting B2 Agonists Market
12.1. Australia Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Short-Acting B2 Agonists Market
13.1. Indonesia Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Short-Acting B2 Agonists Market
14.1. South Korea Short-Acting B2 Agonists Market Overview
14.2. South Korea Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Short-Acting B2 Agonists Market
15.1. Western Europe Short-Acting B2 Agonists Market Overview
15.2. Western Europe Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Short-Acting B2 Agonists Market
16.1. UK Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Short-Acting B2 Agonists Market
17.1. Germany Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Short-Acting B2 Agonists Market
18.1. France Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Short-Acting B2 Agonists Market
19.1. Italy Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Short-Acting B2 Agonists Market
20.1. Spain Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Short-Acting B2 Agonists Market
21.1. Eastern Europe Short-Acting B2 Agonists Market Overview
21.2. Eastern Europe Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Short-Acting B2 Agonists Market
22.1. Russia Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Short-Acting B2 Agonists Market
23.1. North America Short-Acting B2 Agonists Market Overview
23.2. North America Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Short-Acting B2 Agonists Market
24.1. USA Short-Acting B2 Agonists Market Overview
24.2. USA Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Short-Acting B2 Agonists Market
25.1. Canada Short-Acting B2 Agonists Market Overview
25.2. Canada Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Short-Acting B2 Agonists Market
26.1. South America Short-Acting B2 Agonists Market Overview
26.2. South America Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Short-Acting B2 Agonists Market
27.1. Brazil Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Short-Acting B2 Agonists Market
28.1. Middle East Short-Acting B2 Agonists Market Overview
28.2. Middle East Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Short-Acting B2 Agonists Market
29.1. Africa Short-Acting B2 Agonists Market Overview
29.2. Africa Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Short-Acting B2 Agonists Market Competitive Landscape And Company Profiles
30.1. Short-Acting B2 Agonists Market Competitive Landscape
30.2. Short-Acting B2 Agonists Market Company Profiles
30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Short-Acting B2 Agonists Market Other Major And Innovative Companies
31.1. Perrigo Company plc
31.2. Aurobindo Pharma Ltd.
31.3. Chiesi Farmaceutici S.p.A.
31.4. Cipla Limited
31.5. Hikma Pharmaceuticals PLC
31.6. Amneal Pharmaceuticals Inc.
31.7. Lupin Limited
31.8. Orion Corporation
31.9. Beximco Pharmaceuticals Ltd.
31.10. Micro Labs Limited
31.11. Neuland Laboratories Limited
31.12. Vectura Group plc
31.13. Nephron Pharmaceuticals Corporation
31.14. AdvaCare Pharma USA LLC
31.15. Midas Care Pharmaceuticals Pvt Ltd.
32. Global Short-Acting B2 Agonists Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Short-Acting B2 Agonists Market
34. Recent Developments In The Short-Acting B2 Agonists Market
35. Short-Acting B2 Agonists Market High Potential Countries, Segments and Strategies
35.1 Short-Acting B2 Agonists Market In 2029 - Countries Offering Most New Opportunities
35.2 Short-Acting B2 Agonists Market In 2029 - Segments Offering Most New Opportunities
35.3 Short-Acting B2 Agonists Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us